Valeant Pulls Appeal Of Patent Suit Vs. Three Rivers, Par Pharma
Drug maker Valeant has withdrawn an appeal to a patent infringement lawsuit that had been scheduled for oral arguments before the U.S. Court of Appeals for the Federal Circuit this week....To view the full article, register now.
Already a subscriber? Click here to view full article